Abstract
Background
Nicotine dependence (ND) is characterized by regular smoking, anxiety, irritation, difficulty concentrating, impatience, restlessness, tremor, dizziness, hunger, nicotine demand, and the individual’s reluctance to quit despite knowing the health risks of smoking. Recently, it has been reported that the Neuregulin 3 (NRG3)/Erb-B2 receptor tyrosine kinase 4 (ERBB4) signaling pathway plays a role in ND. NRG3, which is activated after nicotine intake, binds to ERBB4 and causes GABA release. GABA reduces anxiety and tension, which are one of the nicotine withdrawal symptoms. Therefore we aimed to investigate the relationship between NRG3 and ERBB4 gene polymorphisms and ND.
Materials and methods
The study population was comprised of patients with ND (n = 200) and healthy non-smoker control subjects (n = 200) who were matched for age, sex, and compared for comorbidity factors such as alcohol, smoking, duration, and education (age range 18–60). Genotypes were detected by Real-Time PCR using TaqMan technology. The Fagerström Nicotine Dependence Test (FTND) score was 5 and above for the patient group and 0 for the control group. DNA was obtained from whole peripheral blood and six polymorphisms of Neuregulin 3 (NRG3) (rs1836724, rs7562566, and rs10048757) and Erb-B2 Receptor Tyrosine Kinase 4 (ERBB4) (rs1764072, rs6584400, and rs10883934) genes were analyzed by real-time PCR method.
Results
Our findings show that the six selected SNPs are not significantly associated with ND in the Turkish population and no correlation with dependence levels (p > 0.05).
Conclusion
Although our findings do not show a relationship between ND and these polymorphisms, it is the first study to investigate these single nucleotide polymorphisms (SNPs) for the first time in ND and to find some genotypes in the Turkish population when compared to other populations. Also, our findings are important in terms of their contribution to the literature and forensic genetics.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Quach BC, Bray MJ, Gaddis NC, Liu M, Palviainen T, Minica CC, Zellers S, Sherva R, Aliev F, Nothnagel M (2020) Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits. Nat Commun 11(1):1–13
Bidwell L, Palmer R, Brick L, McGeary J, Knopik V (2016) Genome-wide SNP heritability of nicotine dependence as a multidimensional phenotype. Psychol Med 46(10):2059
Kong X, Deng H, Alston T, Kong Y, Wang J (2017) Association of opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with nicotine dependence. Oncotarget 8(48):84329
Romeo-Stuppy K, Dorado D, Bressler D, Sy D, Hausner A (2020) WHO FCTC Article 19: Using the judicial system to fight tobacco. Tob Induc Dis 18:99
Nadalin S, Flego V, Pavlić SD, Volarić D, Badovinac AR, Kapović M, Ristić S (2020) Association between the ACE-I/D polymorphism and nicotine dependence amongst patients with lung cancer. Biomed Rep 13(6):1–1
Loukola A, Wedenoja J, Keskitalo-Vuokko K, Broms U, Korhonen T, Ripatti S, Sarin A-P, Pitkäniemi J, He L, Häppölä A (2014) Genome-wide association study on detailed profiles of smoking behavior and nicotine dependence in a twin sample. Mol Psychiatry 19(5):615–624
Turner JR, Ray R, Lee B, Everett L, Xiang J, Jepson C, Kaestner KH, Lerman C, Blendy JA (2014) Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Mol Psychiatry 19(7):801–810
Fisher ML, Loukola A, Kaprio J, Turner JR (2015) Role of the neuregulin signaling pathway in nicotine dependence and co-morbid disorders. Int Rev Neurobiol 124:113–131
Gupta R, Qaiser B, He L, Hiekkalinna T, Zheutlin A, Therman S, Ollikainen M, Ripatti S, Perola M, Salomaa V (2017) Neuregulin signaling pathway in smoking behavior. Transl Psychiatry 7(8):e1212–e1212
Noguchi S, Inoue M, Ichikawa T, Kurozumi K, Matsumoto Y, Nakamoto Y, Akiyoshi H, Kamishina H (2021) The NRG3/ERBB4 signaling cascade as a novel therapeutic target for canine glioma. Exp Cell Res 400(2):112504
Mei L, Nave K-A (2014) Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron 83(1):27–49
Benowitz NL (2009) Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol 49:57–71
Zhou L, Fisher ML, Cole RD, Gould TJ, Parikh V, Ortinski PI, Turner JR (2018) Neuregulin 3 signaling mediates nicotine-dependent synaptic plasticity in the orbitofrontal cortex and cognition. Neuropsychopharmacology 43(6):1343–1354
Fagerstrom K-O, Schneider NG (1989) Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12(2):159–182
Miller SA, Dykes D, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
De Ruyck K, Nackaerts K, Beels L, Werbrouck J, De Volder A, Meysman M, Salhi B, Van Meerbeeck J, Thierens H (2010) Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. Pharmacogenomics 11(8):1053–1063
Tang SM, Loke AY (2013) Smoking initiation and personal characteristics of secondary students in Hong Kong. J Adv Nurs 69(7):1595–1606
Kandel DB, Hu MC, Griesler PC, Schaffran C (2007) On the development of nicotine dependence in adolescence. Drug Alcohol Depend 91(1):26–39
MacLeod SL, Chowdhury P (2006) The genetics of nicotine dependence: relationship to pancreatic cancer. World J Gastroenterol WJG 12(46):7433
Grant BF, Hasin DS, Chou SP, Stinson FS, Dawson DA (2004) Nicotine dependence and psychiatric disorders in the united states: results from the national epidemiologic survey on alcohol and relatedconditions. Arch Gen Psychiatry 61(11):1107–1115
Prochaska JJ, Benowitz NL (2016) The past, present, and future of nicotine addiction therapy. Annu Rev Med 67:467–486
Wise RA, Robble MA (2020) Dopamine and addiction. Annu Rev Psychol 71:79–106
Liu W, Li MD (2018) Insights into nicotinic receptor signaling in nicotine addiction: implications for prevention and treatment. Curr Neuropharmacol 16(4):350–370
Vengeliene V, Bilbao A, Molander A, Spanagel R (2008) Neuropharmacology of alcohol addiction. Br J Pharmacol 154(2):299–315
Lanza ST, Vasilenko SA (2015) New methods shed light on age of onset as a risk factor for nicotine dependence. Addict Behav 50:161–164
Ali FRM, Agaku IT, Sharapova SR, Reimels EA, Homa DM (2020) Peer reviewed: onset of regular smoking before age 21 and subsequent nicotine dependence and cessation behavior among US adult smokers. Prev Chron Dis 17:E06
Papathanasiou G, Mamali A, Papafloratos S, Zerva E (2014) Effects of smoking on cardiovascular function: the role of nicotine and carbon monoxide. Health Sci J 8(2):274
Li Ming D (2016) Converging findings from linkage and association analyses on susceptibility genes for smoking addiction. In: Tobacco smoking addiction: epidemiology, genetics, mechanisms, and treatment. Springer, Singapore, pp 153–181
Lessov-Schlaggar CN, Pergadia ML, Khroyan TV, Swan GE (2008) Genetics of nicotine dependence and pharmacotherapy. Biochem Pharmacol 75(1):178–195
Gold AB, Lerman C (2012) Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Hum Genet 131(6):857–876
Karakulah K, Sengul C, Sengul CB (2014) Genetics of Smoking addiction/sigara bagimliliginin genetigi. Psikiyatride Guncel Yaklasimlar/Curr Approaches Psychiatry 6(3):284–294
Falls DL (2003) Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 284:14–30
Fisher M (2019) Investigating the neural correlates of nicotine withdrawal phenotypes in mice: involvement of CREB-dependent NRG3-ErbB4 signaling in mediating anxiety-like behavior. Doctoral dissertation, University of South Carolina
Alaoui-Jamali MA, Morand GB, da Silva SD (2015) ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics. Front Genet 6:17
Starr A, Greif J, Vexler A, Ashkenazy-Voghera M, Gladesh V, Rubin C, Kerber G, Marmor S, Lev-Ari S, Inbar M (2006) ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy. Int J Cancer 119(2):269–274
Sasaki H, Okuda K, Kawano O, Endo K, Yukiue H, Yokoyama T, Yano M, Fujii Y (2007) ErbB4 expression and mutation in Japanese patients with lung cancer. Clin Lung Cancer 8(7):429–433
Kao W-T, Wang Y, Kleinman JE, Lipska BK, Hyde TM, Weinberger DR, Law AJ (2010) Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci 107(35):15619–15624
Gu F, He Y, Mao Y, Lu S, Zhao C, Li X, Zhou C, Hirsch FR (2019) Risk factors for nicotine dependence in Chinese patients with lung cancer. J Int Med Res 47(1):391–397
Bagheri F, Mesrian Tanha H, Mojtabavi Naeini M, Ghaedi K, Azadeh M (2016) Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3’-untranslated region of ErbB4 in breast cancer. Mol Med Rep 13(5):4494–4498
Wei P, Li L, Zhang Z, Zhang W, Liu M, Sheng X (2018) A genetic variant of miR-335 binding site in the ERBB4 3′-UTR is associated with prognosis of ovary cancer. J Cell Biochem 119(7):5135–5142
Acknowledgements
We would like to thank Green Crescent and Mersin University Scientific Research Project Unit for supporting this study as a project coded BAP-SBE TBB (HG) 2014-4 YL.
Funding
This research has not been supported by any institution or organization.
Author information
Authors and Affiliations
Contributions
HGK: Study Design, Formal analysis, Investigation, Methodology, Writing—original draft, Writing—review & editing, Statistical calculations. MEE: Study Design, Sampling condition, Methodology, Laboratory design, Manipulation, Writing- review & editing. ŞGY: Study Design, Sampling condition, Methodology, Laboratory design, Manipulation, Writing- review & editing. CŞ: Diagnosis, Data collection, Biochemical Analysis, Writing- review & editing. CBŞ: Data collection, Data Analysis, Writing- review & editing. KK: Statistical Analysis, Writing- review & editing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical approval
The work described in this article has been carried out by The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans; Uniform Requirements for manuscripts submitted to biomedical journals. Approval was obtained from the Mersin University Faculty of Medicine Clinical Research Ethics Committee for our study.
Informed consent
The study consent form was obtained from all voluntary participants. Consent for publication Written informed consent was obtained from all patients before the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kara, H.G., Erdal, M.E., Yılmaz, S.G. et al. Association of NRG3 and ERBB4 gene polymorphism with nicotine dependence in Turkish population. Mol Biol Rep 48, 5319–5326 (2021). https://doi.org/10.1007/s11033-021-06548-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-021-06548-x